Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

LifeTech Scientific stock

1302.HK
KYG548721177
A14M4J

Price

1.34
Today +/-
-0.01
Today %
-4.04 %

LifeTech Scientific stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the LifeTech Scientific stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the LifeTech Scientific stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the LifeTech Scientific stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze LifeTech Scientific's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

LifeTech Scientific Stock Price History

DateLifeTech Scientific Price
12/20/20241.34 undefined
12/19/20241.40 undefined
12/18/20241.41 undefined
12/17/20241.38 undefined
12/16/20241.40 undefined
12/13/20241.40 undefined
12/12/20241.43 undefined
12/11/20241.48 undefined
12/10/20241.48 undefined
12/9/20241.39 undefined
12/6/20241.36 undefined
12/5/20241.39 undefined
12/4/20241.47 undefined
12/3/20241.49 undefined
12/2/20241.48 undefined
11/29/20241.38 undefined
11/28/20241.36 undefined
11/27/20241.39 undefined
11/26/20241.32 undefined
11/25/20241.32 undefined
11/22/20241.33 undefined
11/21/20241.38 undefined

LifeTech Scientific Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into LifeTech Scientific, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by LifeTech Scientific from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects LifeTech Scientific’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of LifeTech Scientific. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into LifeTech Scientific’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing LifeTech Scientific’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on LifeTech Scientific’s growth potential.

LifeTech Scientific Revenue, EBIT and net profit per share

DateLifeTech Scientific RevenueLifeTech Scientific EBITLifeTech Scientific Net Income
2025e1.81 B undefined465.12 M undefined425.09 M undefined
2024e1.5 B undefined386.58 M undefined330.63 M undefined
20231.27 B undefined339.01 M undefined263.24 M undefined
20221.1 B undefined366.95 M undefined325.34 M undefined
2021925.33 M undefined378.44 M undefined292.47 M undefined
2020642.3 M undefined80.36 M undefined216.09 M undefined
2019668.88 M undefined188.61 M undefined129.2 M undefined
2018556.7 M undefined161.89 M undefined121.08 M undefined
2017409.13 M undefined197.61 M undefined163.47 M undefined
2016352.85 M undefined101.95 M undefined145.65 M undefined
2015311.61 M undefined94.18 M undefined2.36 M undefined
2014282.68 M undefined57.65 M undefined-81.24 M undefined
2013231 M undefined48.7 M undefined-65.7 M undefined
2012181.5 M undefined52.1 M undefined32.4 M undefined
2011140.3 M undefined18.9 M undefined11.8 M undefined
2010104.7 M undefined32 M undefined3.9 M undefined
200979.7 M undefined21 M undefined-4.7 M undefined

LifeTech Scientific Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (B)DOCUMENTS
2009201020112012201320142015201620172018201920202021202220232024e2025e
0.080.10.140.180.230.280.310.350.410.560.670.640.931.11.271.51.81
-31.6534.6229.2927.6222.0810.2813.1816.1935.9420.14-3.8944.0818.5915.5018.6320.29
73.4279.8180.7180.1181.3981.5681.0378.4180.9381.8379.9479.9180.7679.5878.5366.2055.03
588311314518823025227633145553451374787399500
-431132-65-812145163121129216292325263330425
--175.00266.67190.91-303.1324.62-102.477,150.0012.41-25.776.6167.4435.1911.30-19.0825.4828.79
41.923.34444444.344.364.144.394.564.414.4500
-----------------
Details

Keystats

Revenue and Growth

The LifeTech Scientific Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the LifeTech Scientific is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
200920102011201220132014201520162017201820192020202120222023
                             
0.060.080.210.20.230.270.260.650.450.360.351.141.480.831.18
32.82736.539.549.264.8770.9583.4273.7291.1172.55107.14110.04137.09105.19
15.42.75.15.236.912.424.7728.2927.9916.4527.4737.5989.44123.12398.03
16.115.221.224.732.630.8638.440.3539.4170.7499.1399.62129.29241.41483.61
1.53.14.5814.313.9811.7114.7313.8242.1257.63157.8231.9461.2565.01
0.120.130.280.280.370.390.40.810.610.580.611.541.841.42.23
14.51725.728.236.461.23272.17348.35329.94352.73451.7499.68743.71816.03921.46
1.81.71.9132.92.82.522.59129.95307.54333.51569.22191.11972.41804.06
00000006.30000000
6.15.24.517.131.853.178.17110.69151.71202.54258.91304.9364.83442.41656.67
000000000000000
1.933.625.68461.2948.0850.1451.2990.34122.335.94762.683.03
0.020.030.040.080.160.180.40.520.660.951.171.411.352.292.47
0.150.160.310.360.520.570.81.331.271.531.772.953.183.694.7
                             
0000032323535353537373737
0.01-00.250.250.250.250.250.770.790.80.781.611.621.631.64
000.010.04-0.02-0.1-0.070.10.270.450.370.730.881.081.76
000.70.81.42.42.471.380.490.680.691.733.793.682.27
0000000000000191.44-30.35
0.01-00.260.30.230.150.180.871.051.251.152.342.52.93.37
2.21.82.42.6165.6323.7432.1121.518.669.9218.7130.7662.65834.24
3.16.313.820.728.430.9945.0859.7964.8991.26117.53143.51237.14290.88284.58
126.8141.924.421.233.128.8952.37109.2270.195.9488.69150.07202.96226.17355.18
000000000000000
00000002002.4125.08181.3111.055.046.29
0.130.150.040.040.080.070.120.220.160.210.340.490.480.581.48
000067.178.48145.24180021.62228.374.67139.63147.14561.33
80000000000000000
4.75.44.818.8139.4265.99355.1958.3657.3157.3540.9797.7932.0837.1740.93
5.55.44.818.8206.5344.47500.42238.3657.3178.97269.34102.46171.71184.31602.26
0.140.160.050.060.280.410.620.460.210.290.610.60.650.772.08
0.150.160.310.360.520.560.81.331.271.541.762.943.163.675.45
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of LifeTech Scientific provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand LifeTech Scientific's financial health and stability.

Assets

LifeTech Scientific's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that LifeTech Scientific must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of LifeTech Scientific after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into LifeTech Scientific's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20092010201120122013201420152016201720182019202020212022
0101941-53-6726186193167170242332378
446767710142849565660
00000000000000
-159-8-13-13-4120-12-63-68-642255-135
2320-479412189-5795511816-386
0000100060192520
276912131721504047435971
124411423519144126154182274338441388
-5-6-15-8-52-30-218-78-111-64-101-105-275-226
-57-39-29-12610-191111-148-307-255-341-38-458
013-24-20-744126190-37-243-154-236236-232
00000000000000
-10000119048151-20024287-131-118-12
001590000072-350816-152-202
-10-261280117046152-19825-72674-256-215
0-7-110-10-10-60-10-10140
0-19-2000000000000
-325101132730-1390-193-99-53672147-285
6.838.5-3.233.7-17.4-11.42-73.8648.4243.31117.88173.45233.46165.27161.95
00000000000000

LifeTech Scientific stock margins

The LifeTech Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of LifeTech Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for LifeTech Scientific.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the LifeTech Scientific's sales revenue. A higher gross margin percentage indicates that the LifeTech Scientific retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the LifeTech Scientific's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the LifeTech Scientific's total revenue generated. When comparing the revenue margin year over year, investors can gauge the LifeTech Scientific's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the LifeTech Scientific. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the LifeTech Scientific's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

LifeTech Scientific Margin History

LifeTech Scientific Gross marginLifeTech Scientific Profit marginLifeTech Scientific EBIT marginLifeTech Scientific Profit margin
2025e78.57 %25.71 %23.5 %
2024e78.57 %25.72 %22 %
202378.57 %26.75 %20.77 %
202279.64 %33.44 %29.65 %
202180.79 %40.9 %31.61 %
202079.89 %12.51 %33.64 %
201979.96 %28.2 %19.32 %
201881.74 %29.08 %21.75 %
201781.14 %48.3 %39.96 %
201678.37 %28.89 %41.28 %
201581.06 %30.22 %0.76 %
201481.41 %20.39 %-28.74 %
201381.65 %21.08 %-28.44 %
201280.06 %28.71 %17.85 %
201180.54 %13.47 %8.41 %
201079.85 %30.56 %3.72 %
200973.02 %26.35 %-5.9 %

LifeTech Scientific Stock Sales Revenue, EBIT, Earnings per Share

The LifeTech Scientific earnings per share therefore indicates how much revenue LifeTech Scientific has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue LifeTech Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates LifeTech Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of LifeTech Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating LifeTech Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LifeTech Scientific Revenue, EBIT and net profit per share

DateLifeTech Scientific Sales per ShareLifeTech Scientific EBIT per shareLifeTech Scientific Earnings per Share
2025e0.39 undefined0 undefined0.09 undefined
2024e0.32 undefined0 undefined0.07 undefined
20230.29 undefined0.08 undefined0.06 undefined
20220.25 undefined0.08 undefined0.07 undefined
20210.2 undefined0.08 undefined0.06 undefined
20200.15 undefined0.02 undefined0.05 undefined
20190.16 undefined0.05 undefined0.03 undefined
20180.13 undefined0.04 undefined0.03 undefined
20170.09 undefined0.05 undefined0.04 undefined
20160.09 undefined0.03 undefined0.04 undefined
20150.08 undefined0.02 undefined0 undefined
20140.07 undefined0.01 undefined-0.02 undefined
20130.06 undefined0.01 undefined-0.02 undefined
20120.05 undefined0.01 undefined0.01 undefined
20110.04 undefined0.01 undefined0 undefined
20100.05 undefined0.02 undefined0 undefined
20090.02 undefined0.01 undefined-0 undefined

LifeTech Scientific business model

LifeTech Scientific Corp is a leading company in the field of medical technology. The company was founded in 1999 in Beijing, China and has since become a global provider of medical products and solutions. LifeTech Scientific Corp has offices in the USA, Europe, Asia, and Africa and is listed on the Hong Kong Stock Exchange. The business model of LifeTech Scientific Corp is based on innovative medical solutions and products for cardiology and other medical specialties. The company aims to improve treatment options for patients and equip doctors with the best tools and technologies to provide the best diagnosis and treatment options. LifeTech Scientific Corp offers a wide range of products and solutions including diagnostic devices, implantable devices, surgical devices, and accessories. These products can be used in various medical specialties such as cardiology, vascular surgery, neurology, and intensive care. Cardiology is one of the key areas of LifeTech Scientific Corp. The company offers a wide range of products focused on treating heart conditions such as coronary artery disease, heart failure, and arrhythmias. This includes implantable cardiac devices such as Implantable Cardiac Defibrillators (ICDs) and pacemakers used to treat rhythm disorders. LifeTech Scientific Corp's devices are very advanced and provide patients with an excellent quality of life. In addition to cardiology, LifeTech Scientific Corp also offers devices and solutions for other medical specialties. In the field of neurology, for example, the company provides devices for monitoring brain activity and treating epilepsy. In vascular surgery, LifeTech Scientific Corp offers devices for diagnosing and treating aneurysms and narrowing of blood vessels. In intensive care, the company provides devices for ventilation and patient monitoring. The history of LifeTech Scientific Corp is characterized by continuous growth and the development of new products and solutions. In recent years, the company has built strategic partnerships with leading medical institutions and research facilities around the world to advance the development of new technologies and products. Overall, LifeTech Scientific Corp is now one of the leading companies in the field of medical technology, offering innovative solutions for a range of medical specialties. The company is committed to improving patients' quality of life and providing doctors with the best tools and technologies to ensure the best possible treatment. LifeTech Scientific is one of the most popular companies on Eulerpool.com.

LifeTech Scientific SWOT Analysis

Strengths

LifeTech Scientific Corp possesses several strengths that contribute to its success in the market. These include:

  • A robust product portfolio with cutting-edge medical technologies.
  • A strong brand reputation and recognition in the healthcare industry.
  • Strategic partnerships and collaborations with reputable organizations.
  • A highly skilled and experienced workforce.
  • Efficient operations and well-established distribution channels.

Weaknesses

Despite its strengths, LifeTech Scientific Corp also faces certain weaknesses that need to be addressed:

  • Limited geographical presence and market penetration compared to some competitors.
  • Reliance on a small number of key suppliers or partners.
  • Potential vulnerability to disruptions in the global supply chain.
  • High research and development costs for continuous innovation.
  • Limited diversification in product offerings.

Opportunities

LifeTech Scientific Corp can capitalize on various opportunities in the market, including:

  • An increasing global demand for advanced medical devices and technologies.
  • Expansion into emerging markets with rising healthcare expenditures.
  • Acquisition or partnership opportunities to enhance product portfolio or market presence.
  • Advancements in research and development, enabling the development of innovative products.
  • Growing adoption of telemedicine and remote healthcare services.

Threats

LifeTech Scientific Corp must also be aware of potential threats that may impact its business:

  • Intense competition from established players and new entrants in the market.
  • Stringent regulatory requirements and increased scrutiny in the healthcare industry.
  • Technological advancements by competitors, posing a risk of product obsolescence.
  • Economic downturns affecting consumer spending on healthcare products and services.
  • Supply chain disruptions due to natural disasters or global crises.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

LifeTech Scientific Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

LifeTech Scientific historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

LifeTech Scientific shares outstanding

The number of shares was LifeTech Scientific in 2023 — This indicates how many shares 4.446 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue LifeTech Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates LifeTech Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of LifeTech Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating LifeTech Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LifeTech Scientific stock splits

In LifeTech Scientific's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for LifeTech Scientific.

LifeTech Scientific shareholders

%
Name
Stocks
Change
Date
14.99144 % Xie (Yuehui)694,194,928-66,000,0007/3/2024
6.32115 % Lifetech Scientific Corporation 2022 Share Award Scheme292,708,000292,708,0006/28/2024
4.96169 % HHLR Advisors, Ltd.229,756,500-184,388,0009/26/2024
1.44594 % The Vanguard Group, Inc.66,955,734630,0009/30/2024
1.35835 % Bosera Asset Management Co., Ltd.62,900,000-216,0006/30/2024
0.97305 % BlackRock Institutional Trust Company, N.A.45,058,000154,0009/30/2024
0.90381 % Dimensional Fund Advisors, L.P.41,852,000-426,0008/31/2024
0.28169 % BlackRock Advisors (UK) Limited13,044,000296,0009/30/2024
0.25704 % Norges Bank Investment Management (NBIM)11,902,421-1,583,4366/30/2024
0.18939 % State Street Global Advisors (US)8,770,000-30,0009/30/2024
1
2
3
4
5
...
6

LifeTech Scientific Executives and Management Board

Mr. Yuehui Xie

(52)
LifeTech Scientific Executive Chairman of the Board, Chief Executive Officer (since 2006)
Compensation 14.07 M

Mr. Jianxiong Liu

(51)
LifeTech Scientific Chief Financial Officer, Executive Vice President, Executive Director, Company Secretary
Compensation 3.15 M

Mr. Feng Jiang

(60)
LifeTech Scientific Non-Executive Director
Compensation 120,000

Mr. Hsien Tse Liang

(67)
LifeTech Scientific Independent Non-Executive Director
Compensation 120,000

Mr. Wansong Wang

(52)
LifeTech Scientific Independent Non-Executive Director
Compensation 120,000
1
2

LifeTech Scientific Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,730,37-0,020,05-0,520,40
Bank of Communications H Stock
Bank of Communications H
SupplierCustomer0,69-0,20-0,03-0,70-0,600,12
SupplierCustomer0,32-0,180,830,860,72-0,27
1

Most common questions regarding LifeTech Scientific

What values and corporate philosophy does LifeTech Scientific represent?

LifeTech Scientific Corp represents values of innovation, integrity, and commitment to quality. The company's corporate philosophy revolves around advancing healthcare solutions through cutting-edge technologies and research. With a strong focus on developing high-quality medical devices, LifeTech Scientific Corp aims to improve patient outcomes and enhance the overall healthcare industry. By combining scientific expertise with a dedication to customer satisfaction, the company strives to create long-term value for its stakeholders. As a leader in the healthcare sector, LifeTech Scientific Corp aims to provide innovative solutions that positively impact the lives of patients worldwide.

In which countries and regions is LifeTech Scientific primarily present?

LifeTech Scientific Corp primarily operates and has a presence in various countries and regions across the globe. With a global footprint, the company's operations extend to multiple countries and regions, including but not limited to the United States, China, Europe, Asia Pacific, and Latin America. The company's commitment to expanding its reach and serving customers on a global scale demonstrates its ambition and focus on enhancing its market presence worldwide.

What significant milestones has the company LifeTech Scientific achieved?

LifeTech Scientific Corp has achieved several significant milestones throughout its history. Some notable accomplishments include the successful development and commercialization of innovative medical devices and healthcare solutions. The company has also received various awards and recognitions for its contributions to the field. Additionally, LifeTech Scientific Corp has established strong partnerships and collaborations with leading healthcare organizations, further enhancing its reputation and market presence. With a focus on continuous innovation and commitment to improving patient outcomes, the company has rapidly grown and made a name for itself in the industry.

What is the history and background of the company LifeTech Scientific?

LifeTech Scientific Corp is a renowned company specializing in high-quality medical devices and solutions. Founded in [year], the company has established a strong presence in the healthcare industry. With a commitment to innovation and excellent customer service, LifeTech Scientific Corp continuously strives to deliver cutting-edge products that enhance patient care. The company's history is marked by consistent growth and numerous successful partnerships with leading medical institutions. Today, LifeTech Scientific Corp stands as a trusted name in the healthcare market, known for its exceptional products and dedication to improving the lives of patients worldwide.

Who are the main competitors of LifeTech Scientific in the market?

LifeTech Scientific Corp faces competition from various companies in the market. Some of the main competitors include Thermo Fisher Scientific, Illumina Inc., and BD Biosciences. These companies operate in the same industry and provide similar products and services. However, LifeTech Scientific Corp has built a strong reputation and competitive advantage through its innovative solutions and high-quality offerings. With its commitment to research and development, LifeTech Scientific Corp continues to strive for excellence and maintain its position among the top competitors in the market.

In which industries is LifeTech Scientific primarily active?

LifeTech Scientific Corp primarily operates in the life sciences industry.

What is the business model of LifeTech Scientific?

LifeTech Scientific Corp is a leading medical device company specializing in the research, development, and manufacturing of innovative cardiovascular products. The company's business model revolves around designing and producing life-saving devices such as drug-eluting stents and cardiovascular implants. LifeTech Scientific Corp focuses on providing high-quality, technologically advanced medical solutions to healthcare professionals globally. Through continuous research, strategic partnerships, and a commitment to improving patient outcomes, LifeTech Scientific Corp aims to revolutionize the field of cardiovascular medicine. With their strong dedication to innovation and excellence, LifeTech Scientific Corp remains at the forefront of the industry, catering to the ever-evolving needs of healthcare providers and patients worldwide.

What is the P/E ratio of LifeTech Scientific 2024?

The LifeTech Scientific P/E ratio is 18.07.

What is the P/S ratio of LifeTech Scientific 2024?

The LifeTech Scientific P/S ratio is 3.97.

What is the Quality Investing of LifeTech Scientific?

The Quality Investing for LifeTech Scientific is 6/10.

What is the revenue of LifeTech Scientific 2024?

The expected LifeTech Scientific revenue is 1.5 B CNY.

How high is the profit of LifeTech Scientific 2024?

The expected LifeTech Scientific profit is 330.63 M CNY.

What is the business model of LifeTech Scientific

The company LifeTech Scientific Corp specializes in the development, production, and marketing of medical devices and products. It has different divisions that focus on specific applications and offer a wide range of products. The company was founded in 2001 and is headquartered in Shenzhen, China. It is a leading manufacturer of medical devices and has an excellent reputation in the industry. The company strives to develop and provide innovative solutions to improve healthcare. One important part of the company's business model is cardiology, offering a wide range of products such as EKG devices, heart monitoring devices, and various catheters used in the diagnosis and treatment of heart diseases. It also provides comprehensive cardiology services. Another important division is anesthesia, offering various devices and accessories for anesthesia, as well as customized solutions for anesthesia care in hospitals and medical centers. The company also has a division for interventional cardiology, offering devices such as balloon catheters, stents, and guide wire systems used in the diagnosis and treatment of heart diseases. In the radiology division, the company offers a wide range of medical devices such as CT scanners, X-ray machines, and ultrasound devices. Orthopedics is another important part of the company's business model, offering a wide range of products such as implants, prosthetics, and instruments used in the surgical treatment of orthopedic conditions. The company also has a rehabilitation division, offering a variety of devices and therapies. LifeTech Scientific Corp collaborates with various international organizations and research institutions to develop new technologies and innovations in the field of medical devices. The company also invests in research and development to expand its portfolio of products and services and ensure customer satisfaction. Overall, LifeTech Scientific Corp offers products and services in various medical divisions and strives for continuous development of new technologies and innovations to improve patient care. The company has earned an excellent reputation in the industry and always aims to meet the needs of its customers.

What is the LifeTech Scientific dividend?

LifeTech Scientific pays a dividend of 0 CNY distributed over payouts per year.

How often does LifeTech Scientific pay dividends?

The dividend cannot currently be calculated for LifeTech Scientific or the company does not pay out a dividend.

What is the LifeTech Scientific ISIN?

The ISIN of LifeTech Scientific is KYG548721177.

What is the LifeTech Scientific WKN?

The WKN of LifeTech Scientific is A14M4J.

What is the LifeTech Scientific ticker?

The ticker of LifeTech Scientific is 1302.HK.

How much dividend does LifeTech Scientific pay?

Over the past 12 months, LifeTech Scientific paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, LifeTech Scientific is expected to pay a dividend of 0 CNY.

What is the dividend yield of LifeTech Scientific?

The current dividend yield of LifeTech Scientific is .

When does LifeTech Scientific pay dividends?

LifeTech Scientific pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of LifeTech Scientific?

LifeTech Scientific paid dividends every year for the past 0 years.

What is the dividend of LifeTech Scientific?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is LifeTech Scientific located?

LifeTech Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von LifeTech Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of LifeTech Scientific from 12/20/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did LifeTech Scientific pay the last dividend?

The last dividend was paid out on 12/20/2024.

What was the dividend of LifeTech Scientific in the year 2023?

In the year 2023, LifeTech Scientific distributed 0 CNY as dividends.

In which currency does LifeTech Scientific pay out the dividend?

The dividends of LifeTech Scientific are distributed in CNY.

All fundamentals about LifeTech Scientific

Our stock analysis for LifeTech Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LifeTech Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.